The Management and Treatment of Parkinson's Disease
Post Test

A score of 70% must be achieved to receive continuing education credits.
 
1. The average age of onset of Parkinson’s Disease (PD) is 60 with 5% showing symptoms prior to age 40.
  True
   False
2. Motor signs and symptoms include all but which of the following:
  a. Decreased arm swing
  b. Constipation
c. Bradykinesia
 d. Rest tremor
3. Non Medical therapies include all but which of the following
 a. Strengthening and cardiovascular exercise
 b. Dance therapy
 c. Acupuncture
 d. Glycemic Control
4. Although, treatment should be individualized, it should be started when symptoms have an impact on
a. Social relations
 b. Professional life
 c. Quality of Live
 d. Activities of daily living
  e. All of the above
5. Pharmacotherapy for PD include:
 a. COMT inhibitors
 b. Amantadine
 c. Dopamine agonists
 d. Anticholinergics
 e. Levodopa
 f.  MAO-B inhibitors
 g. All of the above
6. In early PD, the ADAGIO study confirmed symptomatic benefit with use of MAO-B inhibitor versus placebo.
 True
  False
7. New strategies for treatment of severe fluctuations include:
  a. Surgical therapy
 b. Apomorphine rescue treatment
 c. LD intestinal infusion
  d. All of the above
8. Deep brain stimulation candidates include those with advanced PD and medical treatment has been unsuccessful.
 True
  False
9. According to the American Academy of Neurology Practice Parameter for the Initiation of Treatment, levodopa provides superior motor benefit, but at a higher risk of dyskinesia.
   True
   False
10. PD patients may have one year from diagnosis to when motor symptoms begin.
   True
   False

 

Activity evaluation and improvement process:

Please rate this activity on the following scale:
4 - Excellent        3 - Good        2 - Fair        1 - Poor
1.Based on the content presented I am better able to:  
  • Review the American Academy of Neurology's Treatment Guidelines for Parkinson's disease
    4        3        2        1
  • Compare and contrast the efficacy and safety of dopamine agonists, levodopa and monamine oxidase inhibitors
    4        3        2        1
  • Describe current neuroprotection strategies and recent trials
    4        3        2        1
  • Describe the impact of combination therapies on patients' "OFF" (immobile) time
    4        3        2        1
  • Recognize what patients are candidates for surgical management of advanced PD
    4        3        2        1
2. Activity met my expectations    4        3        2        1  
3. Activity was free of bias    4        3        2        1
4. Activity content was understandable    4        3        2        1
5. Presenter was free of bias    4        3        2        1
6. Method of learning was beneficial    4        3        2        1
7. Presenter covered material to extent expected    4        3        2        1
8. Comments: 
9. What other topics are of interest to you?


Due to the content of this activity, I will change my practice patterns by:

Providing appropriate education to patients
Work with our neurologists and primary care providers to establish an appropriate referral / treatment choice
Be aware of the challenges of managing Parkinson’s Disease
My practice patterns will not change
Other    Specify:

Continuing education implies quality improvement in behavior. As part of our quality improvement process, NAMCP/AAMCN will contact you 3 months from your post test submission to monitor change.
Name:  
Profession: MD  DO  RN  LPN  Other
Company:  
Mailing Address:  
City, State, Zip:  
Phone:  
Fax:  
Email:  
Heard About Activity By: eNews  Colleague  Internet    JMCM Article
 Email   Phone
 
Send my certificate by: U.S. Mail             Email